ATE253363T1 - Nikotinhaltige verabreichungssysteme - Google Patents

Nikotinhaltige verabreichungssysteme

Info

Publication number
ATE253363T1
ATE253363T1 AT00929696T AT00929696T ATE253363T1 AT E253363 T1 ATE253363 T1 AT E253363T1 AT 00929696 T AT00929696 T AT 00929696T AT 00929696 T AT00929696 T AT 00929696T AT E253363 T1 ATE253363 T1 AT E253363T1
Authority
AT
Austria
Prior art keywords
delivery systems
nicotine
nicotine delivery
encapsulated
microencapsules
Prior art date
Application number
AT00929696T
Other languages
English (en)
Inventor
David Leslie Mcneight
Original Assignee
Fluid Technologies Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fluid Technologies Plc filed Critical Fluid Technologies Plc
Application granted granted Critical
Publication of ATE253363T1 publication Critical patent/ATE253363T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT00929696T 1999-05-13 2000-05-11 Nikotinhaltige verabreichungssysteme ATE253363T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9911037.1A GB9911037D0 (en) 1999-05-13 1999-05-13 Nicotine delivery service
PCT/GB2000/001807 WO2000069440A2 (en) 1999-05-13 2000-05-11 Nicotine delivery systems

Publications (1)

Publication Number Publication Date
ATE253363T1 true ATE253363T1 (de) 2003-11-15

Family

ID=10853329

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00929696T ATE253363T1 (de) 1999-05-13 2000-05-11 Nikotinhaltige verabreichungssysteme

Country Status (12)

Country Link
US (2) US20060120974A1 (de)
EP (1) EP1176961B1 (de)
JP (1) JP2002544230A (de)
CN (1) CN1200711C (de)
AT (1) ATE253363T1 (de)
AU (1) AU4769900A (de)
DE (1) DE60006376T2 (de)
DK (1) DK1176961T3 (de)
ES (1) ES2209882T3 (de)
GB (1) GB9911037D0 (de)
PT (1) PT1176961E (de)
WO (1) WO2000069440A2 (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076605A1 (de) * 2001-03-23 2002-10-03 Symrise Gmbh & Co. Kg Verfahren zur herstellung von einkapselungen
CN100334962C (zh) † 2001-11-15 2007-09-05 三荣源有限公司 微囊及含微囊的经口组合物
GB2396107A (en) * 2002-10-24 2004-06-16 Micap Plc Micro-organism microcapsules
GB2395124A (en) * 2002-11-16 2004-05-19 Fluid Technologies Plc Palatable microcapsules
GB2406053B (en) * 2003-09-10 2008-08-20 Micap Plc Antimicrobial composition
PL1711058T3 (pl) 2004-01-23 2022-02-07 Eden Research Plc Sposoby zabijania nicieni obejmujące aplikację składnika terpenowego
GB2413563A (en) * 2004-04-27 2005-11-02 Micap Plc Composition comprising a biocide encapsulated within a fungal cell
GB2418654A (en) * 2004-09-29 2006-04-05 Micap Plc Microbial encapsulation
WO2005102508A1 (en) * 2004-04-27 2005-11-03 Micap Plc Microbial encapsulation
DK1753529T3 (da) 2004-05-20 2013-11-11 Eden Research Plc Komposition indeholdende en hul glucan-partikel eller en hul cellevægspartikel, der indkapsler en terpenkomponent, fremgangsmåder til fremstilling og anvendelse af disse
EP2982244B1 (de) 2005-11-30 2020-11-18 Eden Research Plc Thymolhaltige Insektizide Kapseln und Verfahren zu ihrer Herstellung und Verwendung
EP1954130B1 (de) 2005-11-30 2018-06-13 Eden Research Plc Verfahren umfassend terpenmischungen enthaltend thymol und citral
USD613029S1 (en) 2007-11-20 2010-04-06 Mars, Incorporated Candy
EP2379449B1 (de) 2009-01-19 2021-04-21 W.R. Grace & CO. - CONN. VERLEIHUNG VON MESOPOROSITÄT BEI ZEOLITHEN MIT GERINGEM Si-/Al-VERHÄLTNIS
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
USD658347S1 (en) * 2011-01-07 2012-05-01 Gottardi B Maia Alexandre Pet treat
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
GB201220940D0 (en) 2012-11-21 2013-01-02 Eden Research Plc Method P
USD715019S1 (en) * 2013-04-19 2014-10-14 Pawsome Dog Training, LLC Dog treat
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
EP3871515B1 (de) 2014-05-27 2025-04-16 R. J. Reynolds Tobacco Company Nikotinsalze, co-kristalle und salz-co-kristallkomplexe
EP3212159A4 (de) * 2014-10-29 2018-06-27 The Regents of the University of California Trägerstoffe zur bioaktiven abgabe
US10881133B2 (en) 2015-04-16 2021-01-05 R.J. Reynolds Tobacco Company Tobacco-derived cellulosic sugar
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
WO2017089931A1 (en) 2015-11-25 2017-06-01 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10499684B2 (en) 2016-01-28 2019-12-10 R.J. Reynolds Tobacco Company Tobacco-derived flavorants
US11154087B2 (en) 2016-02-02 2021-10-26 R.J. Reynolds Tobacco Company Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds
US11091446B2 (en) 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
EP4635478A3 (de) 2017-09-05 2026-01-07 R. J. Reynolds Tobacco Company Nikotinsalze, co-kristalle und salz-co-kristallkomplexe
US20190307082A1 (en) 2018-04-05 2019-10-10 R.J. Reynolds Tobacco Company Oriental tobacco production methods
CN112384504A (zh) 2018-06-15 2021-02-19 R.J.雷诺兹烟草公司 烟碱的纯化
USD920628S1 (en) 2019-11-26 2021-06-01 Canopy Growth Corporation Confectionery product
WO2021116865A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents for oral composition
WO2021116855A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions and methods of manufacture
CA3211601A1 (en) 2021-03-09 2022-09-15 Jr. Darrell Eugene Holton Oral products and methods of manufacture
US20220354785A1 (en) 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
EP4333650A1 (de) 2021-05-06 2024-03-13 Nicoventures Trading Limited Orale zusammensetzungen und zugehörige verfahren zur verminderung von halsreizungen
MX2024003998A (es) 2021-09-30 2024-06-03 Nicoventures Trading Ltd Producto oral con una amina basica y un agente de emparejamiento ionico.
MX2024005869A (es) 2021-11-15 2024-07-15 Nicoventures Trading Ltd Productos con caracteristicas sensoriales mejoradas.
US20250241356A1 (en) 2022-06-24 2025-07-31 Michael S. Daniel Oral composition comprising receptor modulator
GB202214771D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
WO2024074843A1 (en) 2022-10-07 2024-04-11 Nicoventures Trading Limited Oral product
GB202214803D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
GB202214775D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
EP4598366A1 (de) 2022-10-07 2025-08-13 Nicoventures Trading Limited Orales produkt
EP4598365A1 (de) 2022-10-07 2025-08-13 Nicoventures Trading Limited Orales produkt
WO2024095163A1 (en) 2022-11-01 2024-05-10 Nicoventures Trading Limited Oral composition comprising encapsulated ph adjusting agent
GB202216465D0 (en) 2022-11-04 2022-12-21 Nicoventures Trading Ltd Oral product
WO2024095011A1 (en) 2022-11-04 2024-05-10 Nicoventures Trading Limited Oral product
WO2024180481A1 (en) 2023-02-28 2024-09-06 Nicoventures Trading Limited Caffeine-containing oral product
GB202304445D0 (en) 2023-03-27 2023-05-10 Nicoventures Trading Ltd Oral product
GB202307278D0 (en) 2023-05-16 2023-06-28 Nicoventures Holdings Ltd Oral product
GB202307279D0 (en) 2023-05-16 2023-06-28 Nicoventures Trading Ltd Oral product
EP4585055A1 (de) 2024-01-12 2025-07-16 Nicoventures Trading Limited Orales produkt mit probiotischer komponente
EP4599698A1 (de) 2024-02-07 2025-08-13 Nicoventures Trading Limited Produkte mit sensorischen mitteln
EP4602929A1 (de) 2024-02-19 2025-08-20 Nicoventures Trading Limited Orales produkt mit pulverbeschichtung
EP4623708A1 (de) 2024-03-26 2025-10-01 Nicoventures Trading Limited Süssstoffzusammensetzung für in beutel verpackte orale produkte
EP4623702A1 (de) 2024-03-27 2025-10-01 Nicoventures Trading Limited Orales produkt
EP4631502A1 (de) 2024-04-12 2025-10-15 Nicoventures Trading Limited Verwendung von flavonen wie quercetin zur steigerung der kognitiven funktion und zur verringerung der nervosität
WO2026013602A1 (en) 2024-07-10 2026-01-15 Rai Strategic Holdings, Inc. Oral products

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317576D0 (en) * 1983-06-29 1983-08-03 Shaw A S W Consumer tobacco products
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5525351A (en) * 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
US5830463A (en) * 1993-07-07 1998-11-03 University Technology Corporation Yeast-based delivery vehicles
GB2299756A (en) * 1995-03-29 1996-10-16 Gilbert Falkingham Clayton Gelatinous pastille containing nicotine
WO1997038662A2 (en) * 1996-04-12 1997-10-23 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
US6358060B2 (en) * 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen

Also Published As

Publication number Publication date
PT1176961E (pt) 2004-03-31
EP1176961A2 (de) 2002-02-06
WO2000069440A2 (en) 2000-11-23
DK1176961T3 (da) 2004-03-15
DE60006376T2 (de) 2004-09-09
EP1176961B1 (de) 2003-11-05
GB9911037D0 (en) 1999-07-14
CN1367692A (zh) 2002-09-04
ES2209882T3 (es) 2004-07-01
JP2002544230A (ja) 2002-12-24
DE60006376D1 (de) 2003-12-11
US20070269417A1 (en) 2007-11-22
WO2000069440A3 (en) 2001-04-05
CN1200711C (zh) 2005-05-11
US20060120974A1 (en) 2006-06-08
AU4769900A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
DK1176961T3 (da) Nikotinafgivende systemer
BR9801027B1 (pt) sistema de distribuiÇço de medicamentos.
IT1303444B1 (it) Dispositivo di rilascio di farmaci.
DK1115381T3 (da) Indgivelsessystem til proteinformige lægemidler, hvor der anvendes membranmimetika
DE69822529D1 (de) Stentanbringungssystem
NO994837D0 (no) Intravesikal medikamentavleveringssystem
NO20000735L (no) Legemiddel leveringsanordning for vedvarende frigivelse
DE69711045D1 (de) Vitamin c abgabesystem
PT1051217E (pt) Sistema de controlo osmotico de administracao de medicamento
EP0981333A4 (de) Neuartiges system zur verabreichung von aktiven medikamenten mittels eines akustischen verfahrens
DE69926644D1 (de) Medikamentenzufuhrsysteme
DE59812228D1 (de) Tensidsysteme für flüssige wässrige zubereitungen
TR28155A (tr) Aktif madde sevk sistemi.
NO20004523L (no) Avleveringssystem for Õ modulere immunrespons
DE69932415D1 (de) Im aufzug gebrauchtes meldungs-lieferungssystem
TR27244A (tr) Ilac dagitim aleti.
ZA200000610B (en) Micro-osmotic controlled drug delivery systems.
NL1006015A1 (nl) Toedieninrichting.
IT1317513B1 (it) Procedimento atto all'esercizio di un sistema di alimentazione delcarburante.
NL1006855A1 (nl) Sproei-installatie.
ZA974920B (en) Drug delivery systems.
ES1038124Y (es) Sistema para juegos de mesa.
ES2149684A1 (es) Sistema de aprovechamientos hidroelectricos.
NL1015972A1 (nl) Onbemand sproeisysteem.
DE60008536D1 (de) Topische antiseptische zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1176961

Country of ref document: EP

REN Ceased due to non-payment of the annual fee